SEC Form 4 · accession 0001093557-17-000085
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Kahn
Director
Period of report
Mar 14, 2017
Accepted (ET)
Mar 16, 2017 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 14, 2017 | S | 3,000 | $77.36 | D | 21,304 | I | by Trust |
| Common Stock | holding | — | — | — | 4,791 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee.